Suppr超能文献

直接刺激人体回肠末端和盲肠对胰高血糖素样肽-1、酪酪肽和瘦素的影响:对回肠转位的启示

Effects on GLP-1, PYY, and leptin by direct stimulation of terminal ileum and cecum in humans: implications for ileal transposition.

作者信息

Buchwald Henry, Dorman Robert B, Rasmus Nikolaus F, Michalek Van N, Landvik Nichol M, Ikramuddin Sayeed

机构信息

Department of Surgery, University of Minnesota, Minneapolis, MN.

Department of Surgery, University of Minnesota, Minneapolis, MN.

出版信息

Surg Obes Relat Dis. 2014 Sep-Oct;10(5):780-6. doi: 10.1016/j.soard.2014.01.032. Epub 2014 Feb 17.

Abstract

BACKGROUND

We do not have a unified, scientifically tested theory of causation for obesity and its co-morbidities, nor do we have explanations for the mechanics of the metabolic/bariatric surgery procedures. Integral to proffered hypotheses are the actions of the hormones glucagon-like peptide-1 (GLP-1), peptide YY (PYY), and leptin. The objective of this study was to obtain blood levels of GLP-1, PYY, and leptin after stimulation of the terminal ileum and cecum by a static infusion of a food hydrolysate in morbidly obese patients undergoing a duodenal switch procedure.

SETTING

University Hospital.

METHODS

Plasma levels of GLP-1, PYY, and leptin were obtained at 0, 30, 60, 90, and 120 minutes after instillation of 240 mL of a food hydrolysate into the ileum or cecum.

RESULTS

The mean±SD GLP-1 values by cecal stimulation for 0, 30, 60, 90, and 120 minutes were: 41.3±23.2; 39.6±21.8; 38.9±19.1; 47.4±22.3; 51.7±27.3 pM, and by ileal stimulation: 55.0±32.8; 83.4±16.1; 78.7±23.8; 84.7±23.5; 76.4±25.6. The mean±SD PYY values by cecal stimulation were: 62.1±24.8; 91.1±32.8; 102.1±39.6; 119.6±37.5; 130.3±36.7, and by ileal stimulation: 73.8±41.6; 138.1±17.7; 149.5±23.3; 165.7±24.3; 155.5±29.1. Percent change in PYY levels increased ~150%, GLP-1 increased ~50%, and leptin decreased ~20%.

CONCLUSION

Direct stimulation of the human terminal ileum and cecum by a food hydrolysate elicits significant plasma GLP-1 and PYY elevations and leptin decreases, peaking at 90-120 minutes. The ileal GLP-1 and PYY responses exceed those of the cecum, and the PYY effect is about 3-fold that of GLP-1. The results of this study question the satiety premise for ileal transposition.

摘要

背景

我们没有一个统一的、经过科学验证的肥胖及其合并症的因果理论,也没有对代谢/减肥手术程序的机制做出解释。所提出的假设中不可或缺的是胰高血糖素样肽-1(GLP-1)、肽YY(PYY)和瘦素的作用。本研究的目的是在接受十二指肠转位手术的病态肥胖患者中,通过静态输注食物水解产物刺激回肠末端和盲肠后,获取GLP-1、PYY和瘦素的血液水平。

设置

大学医院。

方法

在向回肠或盲肠滴注240 mL食物水解产物后的0、30、60、90和120分钟时获取GLP-1、PYY和瘦素的血浆水平。

结果

通过盲肠刺激,0、30、60、90和120分钟时GLP-1的平均±标准差(mean±SD)值分别为:41.3±23.2;39.6±21.8;38.9±19.1;47.4±22.3;51.7±27.3 pM,通过回肠刺激时分别为:55.0±32.8;83.4±16.1;78.7±23.8;84.7±23.5;76.4±25.6。通过盲肠刺激时PYY的平均±标准差(mean±SD)值分别为:62.1±24.8;91.1±32.8;102.1±39.6;119.6±37.5;130.3±36.7,通过回肠刺激时分别为:73.8±41.6;138.1±17.7;149.5±23.3;165.7±24.3;155.5±29.1。PYY水平的百分比变化增加了约150%,GLP-1增加了约50%,瘦素降低了约20%。

结论

食物水解产物直接刺激人体回肠末端和盲肠会引起血浆GLP-1和PYY显著升高以及瘦素降低,在90 - 120分钟时达到峰值。回肠对GLP-1和PYY的反应超过盲肠,并且PYY的作用约为GLP-1的3倍。本研究结果对回肠转位的饱腹感前提提出了质疑。

相似文献

1
Effects on GLP-1, PYY, and leptin by direct stimulation of terminal ileum and cecum in humans: implications for ileal transposition.
Surg Obes Relat Dis. 2014 Sep-Oct;10(5):780-6. doi: 10.1016/j.soard.2014.01.032. Epub 2014 Feb 17.
2
Is Glucagon-like peptide-1 for real?
Surg Obes Relat Dis. 2014 Sep-Oct;10(5):786. doi: 10.1016/j.soard.2014.02.006. Epub 2014 Feb 12.
4
Preoperative assessment of gut hormones does not correlate to weight loss after Roux-en-Y gastric bypass surgery.
Surg Obes Relat Dis. 2014 Sep-Oct;10(5):822-8. doi: 10.1016/j.soard.2014.04.018. Epub 2014 Apr 29.
5
Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
Int J Obes (Lond). 2016 Nov;40(11):1699-1706. doi: 10.1038/ijo.2016.121. Epub 2016 Aug 30.
8
Diet shapes the metabolite profile in the intact human ileum, which affects PYY release.
Sci Transl Med. 2024 Jun 19;16(752):eadm8132. doi: 10.1126/scitranslmed.adm8132.
9
Peptide YY and glucagon-like peptide-1 in morbidly obese patients before and after surgically induced weight loss.
Obes Surg. 2007 Dec;17(12):1571-7. doi: 10.1007/s11695-007-9323-8. Epub 2007 Nov 29.

引用本文的文献

1
International expert consensus on surgery for type 2 diabetes mellitus.
BMC Endocr Disord. 2025 Jul 1;25(1):151. doi: 10.1186/s12902-025-01961-w.
2
GLP-1: The Progenitor Hormone.
Obes Surg. 2025 Mar;35(3):1195-1196. doi: 10.1007/s11695-025-07757-0.
3
Design of Natterins-based peptides improves antimicrobial and antiviral activities.
Biotechnol Rep (Amst). 2024 Nov 28;45:e00867. doi: 10.1016/j.btre.2024.e00867. eCollection 2025 Mar.
4
Peptides Used for Heavy Metal Remediation: A Promising Approach.
Int J Mol Sci. 2024 Jun 18;25(12):6717. doi: 10.3390/ijms25126717.
5
Therapeutic proteins: developments, progress, challenges, and future perspectives.
3 Biotech. 2024 Apr;14(4):112. doi: 10.1007/s13205-024-03958-z. Epub 2024 Mar 18.
6
Recent Advances in Pharmaceutical Design: Unleashing the Potential of Novel Therapeutics.
Curr Pharm Biotechnol. 2024;25(16):2060-2077. doi: 10.2174/0113892010275850240102105033.
7
Strategic Approaches to Improvise Peptide Drugs as Next Generation Therapeutics.
Int J Pept Res Ther. 2023;29(4):61. doi: 10.1007/s10989-023-10524-3. Epub 2023 May 24.
8
Valorization of leftover green tea residues through conversion to bioactive peptides using probiotics-aided anaerobic digestion.
Microb Biotechnol. 2023 Feb;16(2):418-431. doi: 10.1111/1751-7915.14155. Epub 2022 Oct 26.
9
In Silico Prediction of Anti-Infective and Cell-Penetrating Peptides from Natterin Toxins.
Pharmaceuticals (Basel). 2022 Sep 13;15(9):1141. doi: 10.3390/ph15091141.
10
Chondroinductive/chondroconductive peptides and their-functionalized biomaterials for cartilage tissue engineering.
Bioact Mater. 2021 Jul 14;9:221-238. doi: 10.1016/j.bioactmat.2021.07.004. eCollection 2022 Mar.

本文引用的文献

1
Contribution of endogenous glucagon-like peptide 1 to glucose metabolism after Roux-en-Y gastric bypass.
Diabetes. 2014 Feb;63(2):483-93. doi: 10.2337/db13-0954. Epub 2013 Oct 2.
2
GLP-1 action and glucose tolerance in subjects with remission of type 2 diabetes after gastric bypass surgery.
Diabetes Care. 2013 Jul;36(7):2062-9. doi: 10.2337/dc12-1535. Epub 2013 Jan 28.
3
Glycemic control after stomach-sparing duodenal-jejunal bypass surgery in diabetic patients with low body mass index.
Surg Obes Relat Dis. 2012 Jul-Aug;8(4):375-80. doi: 10.1016/j.soard.2012.01.017. Epub 2012 Feb 2.
5
Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes.
Obesity (Silver Spring). 2012 Jun;20(6):1266-72. doi: 10.1038/oby.2011.377. Epub 2012 Jan 19.
7
Nutritional regulation of glucagon-like peptide-1 secretion.
J Physiol. 2009 Jan 15;587(1):27-32. doi: 10.1113/jphysiol.2008.164012. Epub 2008 Nov 10.
8
Peptide YY(1-36) and peptide YY(3-36): Part I. Distribution, release and actions.
Obes Surg. 2006 May;16(5):651-8. doi: 10.1381/096089206776944959.
9
The biology of incretin hormones.
Cell Metab. 2006 Mar;3(3):153-65. doi: 10.1016/j.cmet.2006.01.004.
10
Effects of load, and duration, of duodenal lipid on antropyloroduodenal motility, plasma CCK and PYY, and energy intake in healthy men.
Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R668-77. doi: 10.1152/ajpregu.00606.2005. Epub 2005 Oct 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验